XML 16 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND SHAREHOLDERS' EQUITY (DEFICIT) - 9 months ended Sep. 30, 2017 - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Series A Redeemable Convertible Preferred Stock
Series B Convertible Preferred Stock
Series C Convertible Preferred Stock
Total
Balance at the beginning of the period (in shares) at Dec. 31, 2016         9,000,000 21,500,000 11,781,984  
Increase (Decrease) in Shares Outstanding                
Conversion of notes payable - related party and accrued interest into stock (in shares) 1,950,768              
Conversion of convertible preferred stock to common stock (in shares) 3,174,523       (9,000,000) (21,500,000) (11,781,984)  
Issuance of stock (in shares) 1,010,225              
Issuance of common stock in connection with merger with Macrocure (in shares) 3,256,898              
Issuance of common stock upon exercise of stock options (in Shares) 3,506             3,506
Balance at the end of the period (in shares) at Sep. 30, 2017 9,395,920              
Balance at the beginning of the period at Dec. 31, 2016         $ 11,800 $ 28,189 $ 30,542  
Increase (Decrease) in Redeemable Convertible Preferred Stock                
Accretion to redemption value         37 90 117  
Conversion of convertible preferred stock to common stock         $ (11,837) $ (28,279) $ (30,659)  
Balance at the beginning of the period at Dec. 31, 2016   $ 145 $ 294 $ (100,670)       $ (100,231)
Increase (Decrease) in Stockholders' Deficit                
Accretion to redemption value   (244)           (244)
Conversion of notes payable - related party and accrued interest into common stock $ 2 31,143           31,145
Conversion of convertible preferred stock to common stock 3 70,772           70,775
Issuance of common stock, net of issuance costs of $947 1 9,052           9,053
Issuance of common stock in connection with merger with Macrocure, net of offering costs of $1,402 3 19,856           19,859
Issuance of common stock upon exercise of stock options   20           20
Foreign currency translation adjustment     (563)         (563)
Stock-based compensation   4,905           4,905
Net loss       (23,134)       (23,134)
Balance at the end of the period at Sep. 30, 2017 $ 9 $ 135,649 $ (269) $ (123,804)       $ 11,585